Overview Financials News + Filings Key Docs Insiders
|
| In millions, except per share items | May-31-14 | May-31-13 | May-31-12 | May-31-11 | May-31-10 |
| | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Knees | 995.7 | 940.0 | 941.8 | | |
| Hips | 649.2 | 632.7 | 633.0 | | |
| Sports, Extremities, Trauma (S.E.T.) | 647.5 | 600.1 | 361.6 | 319.8 | 28.4 |
| Spine, Bone Healing & Microfixation | 446.7 | 408.8 | 411.5 | 319.9 | 34.5 |
| Other | 484.3 | 471.3 | 490.2 | 2,092.5 | 2,635.1 |
| Total revenues | 3,223.4 | 3,052.9 | 2,838.1 | 2,732.2 | 2,698.0 |
| Revenue growth [+] | 5.6% | 7.6% | 3.9% | 1.3% | |
| Knees | 5.9% | -0.2% | | | |
| Hips | 2.6% | 0.0% | | | |
| Sports, Extremities, Trauma (S.E.T.) | 7.9% | 66.0% | 13.1% | 1027.2% | |
| Spine, Bone Healing & Microfixation | 9.3% | -0.7% | 28.6% | 826.4% | |
| Dental | 0.8% | -4.0% | -0.7% | 916.2% | |
| Cost of goods sold | 1,040.2 | 873.4 | 775.5 | 838.7 | 819.9 |
| Gross profit | 2,183.2 | 2,179.5 | 2,062.6 | 1,893.5 | 1,878.1 |
| Gross margin | 67.7% | 71.4% | 72.7% | 69.3% | 69.6% |
| Selling, general and administrative | 1,393.2 | 1,312.5 | 1,172.2 | 1,041.7 | 1,042.3 |
| Research and development | 169.6 | 150.3 | 126.8 | 119.4 | 106.6 |
| EBITDA [+] | 814.4 | 898.3 | 945.8 | 913.5 | 904.2 |
| EBITDA growth | -9.3% | -5.0% | 3.5% | 1.0% | |
| EBITDA margin | 25.3% | 29.4% | 33.3% | 33.4% | 33.5% |
| Depreciation and amortization | 194.0 | 181.6 | 182.2 | 181.1 | 175.0 |
| EBITA | 620.4 | 716.7 | 763.6 | 732.4 | 729.2 |
| EBITA margin | 19.2% | 23.5% | 26.9% | 26.8% | 27.0% |
| Amortization of intangibles | 307.2 | 313.8 | 327.2 | 367.9 | 372.6 |
| EBIT [+] | 313.2 | 402.9 | 436.4 | 364.5 | 356.6 |
| EBIT growth | -22.3% | -7.7% | 19.7% | 2.2% | |
| EBIT margin | 9.7% | 13.2% | 15.4% | 13.3% | 13.2% |
| Non-recurring items [+] | | 567.4 | 529.8 | 941.4 | |
| Asset impairment | | 567.4 | 529.8 | 941.4 | |
| Interest expense, net [+] | 348.1 | 398.3 | 477.2 | 495.6 | 516.4 |
| Interest expense | 355.9 | 398.8 | 479.8 | 498.9 | 516.4 |
| Interest income | 7.8 | 0.5 | 2.6 | 3.3 | |
| Other income (expense), net | -5.0 | -178.3 | -20.2 | 7.9 | 18.1 |
| Pre-tax income | -39.9 | -741.1 | -590.8 | -1,064.6 | -141.7 |
| Income taxes | -115.8 | -117.7 | -132.0 | -214.8 | -94.1 |
| Tax rate | 290.2% | 15.9% | 22.3% | 20.2% | 66.4% |
| Net income | 75.9 | -623.4 | -458.8 | -849.8 | -47.6 |
| Net margin | 2.4% | -20.4% | -16.2% | -31.1% | -1.8% |
| |
| |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|